This post explains how clinical trials units (CTUs), trial managers, and pharmacovigilance teams can use qualitative analysis to make safety reporting more efficient under the new UK framework. The primary keyword for this guide is qualitative analysis of safety reporting. The audience is UK-based and international academic trial teams who must implement risk-proportionate approaches introduced into UK law in April 2026. The payoff is a short, practical workflow that combines reflexive thematic insights with AI-enabled transcription and coding to reduce noise, increase transparency, and accelerate decisions.
Run this analysis on your own data
Start freeTopics
- qualitative analysis of safety reporting
- safety reporting qualitative analysis
- AI-enabled qualitative research
Run this analysis on your own data
Evidano codes documents, interviews, survey responses and spreadsheets with AI, with your judgment in control at every step — and a free plan that doesn't expire.
Keep reading
- Commentary on NewsFaster Insights: Qualitative Analysis of Safety ReportingHow to apply AI-enabled qualitative analysis to safety reporting inefficiencies, using findings from PLOS One. Practical steps for CTU researchers and a free Evidano trial.
- Commentary on NewsFaster Safety Reporting: AI qualitative analysisShow how AI qualitative analysis for safety reporting reduces trial burden after April 2026 UK reforms. Practical steps, quotes from PLOS One, and an Evidano demo.
- Commentary on NewsQualitative analysis of safety reporting: AI toolsHow AI-enabled qualitative analysis can reduce clinical trial safety-reporting burden. Qualitative analysis of safety reporting explained with PLOS One evidence and practical next steps.
